Sexually Transmitted Infections

Medicine & Life Sciences

1. Acquired Immunodeficiency Syndrome 10%
2. Africa South of the Sahara 6%
3. Animals 6%
4. Anti-Bacterial Agents 8%
5. Antimicrobial Stewardship 6%
6. Azithromycin 24%
7. Bacterial Vaginosis 15%
8. Belgium 100%
9. Biomarkers 5%
10. Blastomyces 14%
11. Blastomycosis 8%
12. Ceftriaxone 9%
13. Cephalosporins 14%
14. Chlamydia 27%
15. Chlamydia trachomatis 10%
16. Chlorhexidine 8%
17. Chrysosporium 18%
18. Ciprofloxacin 19%
19. Cohort Studies 11%
20. Confidence Intervals 6%
21. Cross-Sectional Studies 7%
22. Cryptococcus neoformans 9%
23. Eastern Africa 5%
24. Ecosystem 10%
25. Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination 6%
26. Epidemics 14%
27. Epidemiology 9%
28. Escherichia coli 5%
29. Ethiopia 8%
30. Feathers 5%
31. Fluoroquinolones 30%
32. Fungal Spores 5%
33. Fungi 13%
34. Genes 6%
35. Globus Pallidus 8%
36. Gonorrhea 60%
37. Greenland 5%
38. Guidelines 9%
39. Heterosexuality 11%
40. HIV 90%
41. HIV Infections 13%
42. Horizontal Gene Transfer 10%
43. Human Herpesvirus 2 11%
44. Immune Reconstitution Inflammatory Syndrome 5%
45. Incidence 9%
46. Infection 22%
47. Kenya 18%
48. Linear Models 10%
49. Logistic Models 5%
50. Lymphogranuloma Venereum 5%
51. Macrolides 45%
52. Male Circumcision 5%
53. Mass Spectrometry 6%
54. Microbial Drug Resistance 10%
55. Microbiota 5%
56. Monkeypox virus 6%
57. Mouthwashes 16%
58. Mutation 8%
59. Mycology 5%
60. Mycoplasma genitalium 28%
61. Mycoses 17%
62. Neisseria 37%
63. Neisseria gonorrhoeae 69%
64. Neisseria meningitidis 9%
65. Neurosyphilis 5%
66. Observational Studies 6%
67. Onygenales 14%
68. Oropharynx 5%
69. Polymerase Chain Reaction 6%
70. Population 21%
71. Post-Exposure Prophylaxis 5%
72. Pre-Exposure Prophylaxis 61%
73. Primary Health Care 5%
74. Proteome 8%
75. Quinolones 13%
76. Reagins 7%
77. Ribosomal Proteins 7%
78. Risk-Taking 15%
79. SARS Virus 7%
80. Sexual and Gender Minorities 68%
81. Sexual Behavior 22%
82. Sexual Health 6%
83. Sexual Partners 22%
84. Sexually Transmitted Diseases 72%
85. Skin 5%
86. South Africa 58%
87. Southern Africa 6%
88. Streptococcus pneumoniae 5%
89. Syndemic 6%
90. Syphilis 82%
91. Systematic Reviews 12%
92. Therapeutics 6%
93. Treponema pallidum 40%
94. Trichomonas vaginalis 5%
95. Uganda 8%
96. Uncertainty 7%
97. Urease 8%
98. Urine 7%
99. Whole Genome Sequencing 7%